MARKET

CTKB

CTKB

Cytek Biosciences, Inc.
NASDAQ
4.480
+0.010
+0.22%
After Hours: 4.740 +0.26 +5.81% 19:53 06/26 EDT
OPEN
4.490
PREV CLOSE
4.470
HIGH
4.630
LOW
4.420
VOLUME
3.42M
TURNOVER
--
52 WEEK HIGH
6.18
52 WEEK LOW
2.900
MARKET CAP
578.56M
P/E (TTM)
-7.7589
1D
5D
1M
3M
1Y
5Y
1D
Cytek Biosciences Announces Chief Legal Officer Transition
TipRanks · 2d ago
Cytek Biosciences Chief Legal Officer Valerie Barnett to exit June 29
PUBT · 2d ago
Weekly Report: what happened at CTKB last week (0615-0619)?
Weekly Report · 6d ago
Cytek Biosciences Stockholders Back Board, Pay and Auditor
TipRanks · 06/16 20:39
Cytek Biosciences shareholders approve executive pay in advisory vote
PUBT · 06/16 20:08
Weekly Report: what happened at CTKB last week (0608-0612)?
Weekly Report · 06/15 10:33
Cytek Biosciences director Glenn P. Muir files initial beneficial ownership statement
PUBT · 06/12 23:30
Cytek Biosciences to present at Singular Research Las Vegas Invitational Conference
PUBT · 06/10 20:05
More
About CTKB
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.

Webull offers Cytek Biosciences Inc stock information, including NASDAQ: CTKB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTKB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTKB stock methods without spending real money on the virtual paper trading platform.